SynthesisFrontiers in pharmacology2026

Trilaciclib for prophylaxis of chemotherapy-induced myelosuppression in solid tumor patients: a systematic review and meta-analysis.

Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.